1. Home
  2. LSBK vs QNCX Comparison

LSBK vs QNCX Comparison

Compare LSBK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

HOLD

Current Price

$14.80

Market Cap

110.0M

Sector

Finance

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.31

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
QNCX
Founded
1891
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.0M
139.2M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
LSBK
QNCX
Price
$14.80
$3.31
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
9.2K
808.9K
Earning Date
01-23-2026
11-12-2025
Dividend Yield
2.46%
N/A
EPS Growth
105.28
N/A
EPS
1.21
N/A
Revenue
$27,774,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.16
N/A
Revenue Growth
9.61
N/A
52 Week Low
$11.50
$0.72
52 Week High
$16.95
$4.55

Technical Indicators

Market Signals
Indicator
LSBK
QNCX
Relative Strength Index (RSI) 55.18 49.75
Support Level $14.53 $3.18
Resistance Level $14.98 $3.80
Average True Range (ATR) 0.21 0.31
MACD -0.04 -0.13
Stochastic Oscillator 40.91 10.23

Price Performance

Historical Comparison
LSBK
QNCX

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: